Cargando…

CD8(+)γδ T Cells Are More Frequent in CMV Seropositive Bone Marrow Grafts and Display Phenotype of an Adaptive Immune Response

The role of gamma delta (γδ) T cells in human cytomegalovirus (HCMV) immune surveillance has been the focus of research interest for years. Recent reports have shown a substantial clonal proliferation of γδ T cells in response to HCMV, shedding light on the adaptive immune response of γδ T cells. Ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaballa, Ahmed, Arruda, Lucas C. M., Rådestad, Emelie, Uhlin, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925825/ https://www.ncbi.nlm.nih.gov/pubmed/31885619 http://dx.doi.org/10.1155/2019/6348060

Ejemplares similares

Revisiting the Role of γδ T Cells in Anti-CMV Immune Response after Transplantation
por: Gaballa, Ahmed, et al.
Publicado: (2021)

γδ T cells take on CMV
por: Van Epps, Heather L.
Publicado: (2005)

Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors
por: Pita-Lopez, María Luisa, et al.
Publicado: (2009)

Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity
por: Kirisri, Similan, et al.
Publicado: (2021)

604 Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

Gamma delta T-cell reconstitution after allogeneic HCT: A platform for cell therapy
por: Gaballa, Ahmed, et al.
Publicado: (2022)

Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients
por: McBride, Jacqueline M, et al.
Publicado: (2019)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients
por: Kim, Jong Man, et al.
Publicado: (2015)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2017)

Donor CMV Reactivation as a Novel Risk Factor for CMV Replication in Seropositive Liver Transplant Recipients
por: Limaye, Ajit P., et al.
Publicado: (2020)

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
por: Ljungman, Per, et al.
Publicado: (2020)

Lack of cytomegalovirus (CMV)-specific cell-mediated immune response using QuantiFERON-CMV assay in CMV-seropositive healthy volunteers: fact not artifact
por: Valle-Arroyo, Jorge, et al.
Publicado: (2020)

1198. Measurement of Pre-transplant Anti-cytomegalovirus (CMV) Immunoglobulin G Titer to Predict Risk of CMV Infection in CMV-seropositive Kidney Transplant Recipients
por: Kirisri, Similan, et al.
Publicado: (2020)

Lower CD28+ T cell proportions were associated with CMV-seropositivity in patients with Hashimoto’s thyroiditis
por: Prelog, Martina, et al.
Publicado: (2013)

Prevalence, Magnitude, and Genotype Distribution of Urinary Cytomegalovirus (CMV) Shedding Among CMV-Seropositive Children and Adolescents in the United States
por: White, Jodie L, et al.
Publicado: (2019)

Evaluating Thymic Function After Human Hematopoietic Stem Cell Transplantation in the Personalized Medicine Era
por: Gaballa, Ahmed, et al.
Publicado: (2020)

COMBINED EFFECT OF CMV SEROPOSITIVITY AND SYSTEMIC INFLAMMATION ON DEMENTIA PREVALENCE IN CANCER SURVIVORS
por: Vivek, Sithara, et al.
Publicado: (2019)

COMBINED EFFECT OF CMV SEROPOSITIVITY AND SYSTEMIC INFLAMMATION ON DEMENTIA PREVALENCE IN CANCER SURVIVORS
por: Vivek, Sithara, et al.
Publicado: (2019)

Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancer
por: Rådestad, Emelie, et al.
Publicado: (2018)

Humoral and Cellular CMV Responses in Healthy Donors; Identification of a Frequent Population of CMV-Specific, CD4+ T Cells in Seronegative Donors
por: Loeth, Nina, et al.
Publicado: (2012)

A Mortality Analysis of the Cytomegalovirus (CMV) Infection Letermovir Prophylaxis Trial in CMV-Seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation (HCT)
por: Maertens, Johan, et al.
Publicado: (2017)

SARS‐CoV‐2 (COVID‐19)‐specific T cell and B cell responses in convalescent rheumatoid arthritis: Monozygotic twins pair case observation
por: Arruda, Lucas C. M., et al.
Publicado: (2022)

Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients
por: Hoffmann, Jedrzej, et al.
Publicado: (2015)

Seropositivity for CMV and IL-6 levels are associated with grip strength and muscle size in the elderly
por: Kilgour, Alixe HM, et al.
Publicado: (2013)

Differences in immune responses between CMV-seronegative and -seropositive patients with myocardial ischemia and reperfusion
por: Shmeleva, Evgeniya V, et al.
Publicado: (2015)

Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes
por: Norström, Melissa M., et al.
Publicado: (2016)

Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies
por: Litjens, Nicolle H. R., et al.
Publicado: (2017)

Alpha/Beta T-Cell Depleted Grafts as an Immunological Booster to Treat Graft Failure after Hematopoietic Stem Cell Transplantation with HLA-Matched Related and Unrelated Donors
por: Rådestad, E., et al.
Publicado: (2014)

Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease
por: Stikvoort, Arwen, et al.
Publicado: (2017)

Increased IL-21 secretion by aged CD4+T cells is associated with prolonged STAT-4 activation and CMV seropositivity
por: Agrawal, Anshu, et al.
Publicado: (2012)

CMV-Independent Lysis of Glioblastoma by Ex Vivo Expanded/Activated Vδ1+ γδ T Cells
por: Knight, Andrea, et al.
Publicado: (2013)

CMV Seropositive Status Increases Heparanase SNPs Regulatory Activity, Risk of Acute GVHD and Yield of CD34(+) Cell Mobilization
por: Ostrovsky, Olga, et al.
Publicado: (2021)

576. Half-dose Valganciclovir Prophylaxis is Safe and Cost-effective in CMV Seropositive Renal Transplant Recipients
por: shi, yiyun, et al.
Publicado: (2020)

CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients
por: Weber, Simone, et al.
Publicado: (2022)

Assessment of the Interferon-Lambda-3 Polymorphism in the Antibody Response to COVID-19 in Older Adults Seropositive for CMV
por: Nardy, Ariane, et al.
Publicado: (2023)

A CMV-induced adaptive human Vδ1(+) γδ T cell clone recognizes HLA-DR
por: Deseke, Malte, et al.
Publicado: (2022)

Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion
por: Rådestad, Emelie, et al.
Publicado: (2019)

The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation
por: Grosso, Dolores, et al.
Publicado: (2019)

91. Differential Impact of Cytomegalovirus (CMV) Donor (D) Serostatus on Rates and Kinetics of CMV Viremia among CMV Seropositive Recipients (R+) of Ex vivo T-cell Depleted (TCD) and Unmodified (CONV) Hematopoietic Cell Transplants (HCT)
por: Stern, Anat, et al.
Publicado: (2019)

CMV seropositivity and T‐cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study
por: Spyridopoulos, Ioakim, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vqbckn7q7hkffub27krg0rnpt4